×
News Home

Is Citius Pharmaceuticals Inc (CTXR) Stock Worth a Buy Thursday?

Thursday, May 13, 2021 11:51 AM | InvestorsObserver Analysts
Is Citius Pharmaceuticals Inc (CTXR) Stock Worth a Buy Thursday?

Citius Pharmaceuticals Inc (CTXR) stock has gained 74.77% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CTXR stock a score of 70 out of a possible 100.

That rank is chiefly influenced by a fundamental score of 84. In addition to the average rating from Wall Street analysts, CTXR stock has a mean target price of 6. This means analysts expect the stock to rise 209.28% over the next 12 months. CTXR's rank also includes a long-term technical score of 80. The short-term technical score for CTXR is 45.

Overall Score - 70
CTXR has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on CTXR!

What's Happening with CTXR Stock Today

Citius Pharmaceuticals Inc (CTXR) stock is down -7.08% while the S&P 500 has gained 1.04% as of 11:49 AM on Thursday, May 13. CTXR is lower by -$0.15 from the previous closing price of $2.09 on volume of 4,220,821 shares. Over the past year the S&P 500 is up 45.58% while CTXR has gained 74.77%. CTXR lost -$0.47 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Citius Pharmaceuticals Inc (CTXR) Stock.

You May Also Like